These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9339109)

  • 21. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of factor V Leiden and prothrombin G20210A gene mutation.
    Irdem A; Devecioglu C; Batun S; Soker M; Sucakli IA
    Saudi Med J; 2005 Apr; 26(4):580-3. PubMed ID: 15900364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
    Thomassen MC; Castoldi E; Tans G; Magdeleyns EJ; Delaunoit C; Debusscher L; Van Assche KJ; Rosing J
    Haematologica; 2003 Oct; 88(10):1150-6. PubMed ID: 14555311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age as a risk factor for myocardial infarction in Leiden mutation carriers.
    Baranovskaya S; Kudinov S; Fomicheva E; Vasina V; Solovieva D; Khavinson V; Schwartz E
    Mol Genet Metab; 1998 Jun; 64(2):155-7. PubMed ID: 9705241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence of genetic prothrombotic factors (factor V Leiden and II20210 prothrombin mutation) in glomerular nephropathies with or without thrombosis].
    Martínez Ara J; Gómez Rioja R; Riñón C; García Muñoz MS; Ruiz Caravaca ML; Miguel JL
    Nefrologia; 2000; 20(2):139-44. PubMed ID: 10853194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
    Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of Factor V gene A506G mutation (Leiden) in the pathogenesis of ischemic stroke].
    Pongrácz E; Tordai A; Csornai M; Béla Z; Nagy Z
    Ideggyogy Sz; 2003 May; 56(5-6):157-64. PubMed ID: 12861956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of factor V Leiden in healthy Jordanian Arabs.
    Awidi A; Shannak M; Bseiso A; Kailani MA; Kailani MA; Omar N; Anshasi B; Sakarneh N
    Thromb Haemost; 1999 Apr; 81(4):582-4. PubMed ID: 10235443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese.
    Irani-Hakime N; Tamim H; Kreidy R; Almawi WY
    Am J Hematol; 2000 Sep; 65(1):45-9. PubMed ID: 10936863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection of factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP).
    Arruda VR; von Zuben PM; Annichino-Bizzachi JM; Costa FF
    Sangre (Barc); 1996 Oct; 41(5):379-81. PubMed ID: 8986114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor V Leiden in an Urartian, dating back to 1000 BC.
    Alakoç YD; Aka PS; Eğin Y; Akar N
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):679-83. PubMed ID: 19617246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian population.
    Chafa O; Reghis A; Aubert A; Fischer AM
    Br J Haematol; 1997 Jun; 97(3):688-9. PubMed ID: 9207426
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation.
    Hollemaert S; Wautrecht JC; Capel P; Abramowicz MJ; Englert Y; Delbaere A
    Thromb Haemost; 1996 Aug; 76(2):275-7. PubMed ID: 8865546
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden.
    Castaman G; Ruggeri M; Tosetto A; Missiaglia E; Rodeghiero F
    Thromb Haemost; 1996 Aug; 76(2):275. PubMed ID: 8865545
    [No Abstract]   [Full Text] [Related]  

  • 40. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population.
    Baglin TP; Brown K; Williamson D; Baker P; Luddington R
    Thromb Haemost; 1997 Jun; 77(6):1219. PubMed ID: 9241762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.